The genetics of coronary artery disease

Current Opinion in Cardiology

Volumn 27, Issue 3, 2012, Pages 221-227

  Roberts, Robert ^a   Stewart, Alexandre F R ^b  

^a UNIVERSITY OF OTTAWA HEART INSTITUTE   (Canada)

^b Ruddy Canadian Cardiovascular Genetics Centre   (Canada)

Author keywords

coronary artery disease; genetic screening; genetics; Genome Wide Association Studies; prevention

Indexed keywords

CORONARY ARTERY DISEASE; DISEASE PREDISPOSITION; GENE; GENETIC ASSOCIATION; GENETIC DISORDER; GENETIC RISK; GENETIC SCREENING; GENETIC VARIABILITY; GENETICS; HUMAN; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; SINGLE GENE DISORDER; SINGLE NUCLEOTIDE POLYMORPHISM;

CORONARY ARTERY DISEASE; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENETIC MARKERS; HUMANS; MYOCARDIUM; TISSUE THERAPY; UNITED STATES;

EID: 84859914496     PISSN: 02684705     EISSN: 15317080     Source Type: Journal    
DOI: 10.1097/HCO.0b013e3283515b4b     Document Type: Review

References (53)

1. Chan L, Boerwinkle E. Gene-environment interactions and gene therapy in atherosclerosis. Cardiol Rev 1994; 2:130-137.
2. Shepherd J, Cobbe SM, Ford I, et al. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group. N Engl J Med 1995; 333:1301-1307.
3. Downs JR, Clearfield M, Weis S, et al. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study. JAMA 1998; 279:1615-1622. (Pubitemid 28248586)
4. Teslovich TM, Musunuru K, Smith AV, et al. Biological, clinical and population relevance of 95 loci for blood lipids. Nature 2010; 466:707-713.
5. Ehret GB, Munroe PB, Rice KM, et al. Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk. Nature 2011; 478:103-109.
6. Hamosh A, Scott AF, Amberger J, et al. Online Mendelian Inheritance in Man (OMIM), a knowledgebase of human genes and genetic disorders. Nucleic Acids Res 2002; 30:52-55. (Pubitemid 34679502)
7. Byrne BJ, Falk DJ, Pacak CA, et al. Pompe disease gene therapy. Hum Mol Genet 2011; 20:R61-68.
8. Pang AW, MacDonald JR, Pinto D, et al. Towards a comprehensive structural variation map of an individual human genome. Genome Biol 2010; 11:R52.
9. Conrad DF, Pinto D, Redon R, et al. Origins and functional impact of copy number variation in the human genome. Nature 2010; 464:704-712
10. Stranger BE, Forrest MS, Dunning M, et al. Relative impact of nucleotide and copy number variation on gene expression phenotypes. Science 2007; 315:848-853.
11. The International HapMap Project. Nature 2003 426 789-796
12. Via M, Gignoux C, Burchard EG. The 1000 Genomes Project: new opportunities for research and social challenges. Genome Med 2010; 2:3.
13. Helgadottir A, Thorleifsson G, Manolescu A, et al. A common variant on chromosome 9p21 affects the risk of myocardial infarction. Science 2007; 316:1491-1493. (Pubitemid 46906618)
14. McPherson PS, Campbell KP. The ryanodine receptor/Ca2 release channel. J Biol Chem 1993; 268:13765-13768.
15. Samani NJ, Erdmann J, Hall AS, et al. Genomewide association analysis of coronary artery disease. N Engl J Med 2007; 357:443-453. (Pubitemid 47204873)
16. Kathiresan S, Voight BF, Purcell S, et al. Genome-wide association of earlyonset myocardial infarction with single nucleotide polymorphisms and copy number variants. Nat Genet 2009; 41:334-341.
17. Butterworth AS, Braund PS, Farrall M, et al. Large-scale gene-centric analysis identifies novel variants for coronary artery disease. PLoS Genet 2011; 7:e1002260.]
18. Schunkert H, Kö nig IR, Kathiresan S, et al. Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease. Nat Genet 2011; 43:333-338.
19. Gudbjartsson DF, Bjornsdottir US, Halapi E, et al. Sequence variants affecting eosinophil numbers associate with asthma and myocardial infarction. Nat Genet 2009; 41:342-347.
20. Soranzo N, Spector TD, Mangino M, et al. A genome-wide meta-analysis identifies 22 loci associated with eight hematological parameters in the HaemGen consortium. Nat Genet 2009; 41:1182-1190.
21. McPherson R, Pertsemlidis A, Kavaslar N, et al. A common allele on chromosome 9 associated with coronary heart disease. Science 2007; 316:1488-1491. (Pubitemid 46906617)
22. Genome-wide association study of 14 000 cases of seven common diseases and 3000 shared controls. Nature 2007 447 661-678.
23. Clarke R, Peden JF, Hopewell JC, et al. Genetic variants associated with Lp(a) lipoprotein level and coronary disease. N Engl J Med 2009; 361:2518-2528.
24. Trégouë t DA, Kö nig IR, Erdmann J, et al. Genome-wide haplotype association study identifies the SLC22A3-LPAL2-LPA gene cluster as a risk locus for coronary artery disease. Nat Genet 2009; 41:283-285.
25. Erdmann J, Grosshennig A, Braund PS, et al. New susceptibility locus for coronary artery disease on chromosome 3q22.3. Nat Genet 2009; 41:280-282.
26. A genome-wide association study in Europeans and South Asians identifies five new loci for coronary artery disease. Nat Genet 2011 43 339-344.
27. Erdmann J, Willenborg C, Nahrstaedt J, et al. Genome-wide association study identifies a new locus for coronary artery disease on chromosome 10p11.23. Eur Heart J 2011; 32:158-168.
28. Wild PS, Zeller T, Schillert A, et al. A genome-wide association study identifies LIPA as a susceptibility gene for coronary artery disease. Circ Cardiovasc Genet 2011; 4:403-412.
29. Reilly MP, Li M, He J, et al. Identification of ADAMTS7 as a novel locus for coronary atherosclerosis and association of ABO with myocardial infarction in the presence of coronary atherosclerosis: two genome-wide association studies. Lancet 2011; 377:383-392.
30. Aoki A, Ozaki K, Sato H, et al. SNPs on chromosome 5p15.3 associated with myocardial infarction in Japanese population. J Hum Genet 2011; 56:47-51.
31. Yamada Y, Nishida T, Ichihara S, et al. Association of a polymorphism of BTN2A1 with myocardial infarction in East Asian populations. Atherosclerosis 2011; 215:145-152.
32. Wang F, Xu CQ, He Q, et al. Genome-wide association identifies a susceptibility locus for coronary artery disease in the Chinese Han population. Nat Genet 2011; 43:345-349.
33. Broadbent HM, Peden JF, Lorkowski S, et al. Susceptibility to coronary artery disease and diabetes is encoded by distinct, tightly linked SNPs in the ANRIL locus on chromosome 9p. Hum Mol Genet 2008; 17:806-814. (Pubitemid 351359697)
34. Ding H, Xu Y, Wang X, et al. 9p21 is a shared susceptibility locus strongly for coronary artery disease and weakly for ischemic stroke in Chinese Han population. Circ Cardiovasc Genet 2009; 2:338-346.
35. Shen GQ, Li L, Rao S, et al. Four SNPs on chromosome 9p21 in a South Korean population implicate a genetic locus that confers high cross-race risk for development of coronary artery disease. Arterioscler Thromb Vasc Biol 2008; 28:360-365. (Pubitemid 351161212)
36. Hinohara K, Nakajima T, Takahashi M, et al. Replication of the association between a chromosome 9p21 polymorphism and coronary artery disease in Japanese and Korean populations. J Hum Genet 2008; 53:357-359.
37. Kumar J, Yumnam S, Basu T, et al. Association of polymorphisms in 9p21 region with CAD in North Indian population: replication of SNPs identified through GWAS. Clin Genet 2011; 79:588-593.
38. Saleheen D, Alexander M, Rasheed A, et al. Association of the 9p21.3 locus with risk of first-ever myocardial infarction in Pakistanis: case-control study in South Asia and updated meta-analysis of Europeans. Arterioscler Thromb Vasc Biol 2010; 30:1467-1473.
39. Kral BG, Mathias RA, Suktitipat B, et al. A common variant in the CDKN2B gene on chromosome 9p21 protects against coronary artery disease in Americans of African ancestry. J Hum Genet 2011; 56:224-229.
40. Preuss M, Kö nig IR, Thompson JR, et al. Design of the Coronary ARtery DIsease Genome-Wide Replication And Meta-Analysis (CARDIoGRAM) Study: a Genome-wide association meta-analysis involving more than 22 000 cases and 60 000 controls. Circ Cardiovasc Genet 2010; 3:475-483.
41. Skol AD, Scott LJ, Abecasis GR, Boehnke M. Joint analysis is more efficient than replication-based analysis for two-stage genome-wide association studies. Nat Genet 2006; 38:209-213. (Pubitemid 43177235)
42. Dudbridge F, Gusnanto A. Estimation of significance thresholds for genomewide association scans. Genet Epidemiol 2008; 32:227-234. (Pubitemid 351550369)
43. Rotimi CN, Jorde LB. Ancestry and disease in the age of genomic medicine. N Engl J Med 2010; 363:1551-1558.
44. Anderson JL, Horne BD, Kolek MJ, et al. Genetic variation at the 9p21 locus predicts angiographic coronary artery disease prevalence but not extent and has clinical utility. Am Heart J 2008; 156:1155-1162; e1152.
45. Chen Z, Qian Q, Ma G, et al. A common variant on chromosome 9p21 affects the risk of early-onset coronary artery disease. Mol Biol Rep 2009; 36:889-893.
46. Schaefer EJ, Lamon-Fava S, Jenner JL, et al. Lipoprotein(a) levels and risk of coronary heart disease in men. The lipid Research Clinics Coronary Primary Prevention Trial. JAMA 1994; 271:999-1003.
47. Sesso HD, Stampfer MJ, Rosner B, et al. Systolic and diastolic blood pressure, pulse pressure, and mean arterial pressure as predictors of cardiovascular disease risk in Men. Hypertension 2000; 36:801-807.
48. Di Angelantonio E, Sarwar N, Perry P, et al. Major lipids, apolipoproteins, and risk of vascular disease. JAMA 2009; 302:1993-2000.
49. Paynter NP, Chasman DI, Pare G, et al. Association between a literaturebased genetic risk score and cardiovascular events in women. JAMA 2010; 303:631-637.
50. Davies RW, Dandona S, Stewart AFR, et al. Improved prediction of cardiovascular disease based on a panel of single nucleotide polymorphisms identified through genome-wide association studies. Circ Cardiovasc Genet 2010; 3:468-474.
51. Talmud PJ, Cooper JA, Palmen J, et al. Chromosome 9p21.3 coronary heart disease locus genotype and prospective risk of CHD in healthy middle-aged men. Clin Chem 2008; 54:467-474. (Pubitemid 351348157)
52. Dutta A, Henley W, Lang IA, et al. The coronary artery disease associated 9p21 variant and later life 20 year survival to cohort extinction. Circ Cardiovasc Genet 2011; 4:542-548.
53. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002 106 3143-3421.